Increased risk of cognitive impairment in patients with diabetes is associated with metformin.
about
Diabetes mellitus and metformin in hepatocellular carcinomaThe roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer diseaseMolecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisalType 2 diabetes and cognitive impairment: contributions from neuroimagingElevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brainVitamins and type 2 diabetes mellitusMetformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathyMetformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsNeuroenhancement with vitamin B12-underestimated neurological significanceTang-Nai-Kang alleviates pre-diabetes and metabolic disorders and induces a gene expression switch toward fatty acid oxidation in SHR.Cg-Leprcp/NDmcr ratsBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialDiabetes and the brain: issues and unmet needs.Vitamin B12 status in metformin treated patients: systematic review.Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives.Benefits of healthy adipose tissue in the treatment of diabetes.Metformin: good or bad for the brain?Metformin in the diabetic brain: friend or foe?Drugs acting on homeostasis: challenging cancer cell adaptation.Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes.Emerging links between type 2 diabetes and Alzheimer's diseaseModulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer's DiseaseProlonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J micePositive association between plasma amylin and cognition in a homebound elderly population.Glucose regulation and cognitive function after bariatric surgeryAntidiabetic medications and polypharmacyIncreased Glucose Transport into Neurons Rescues Aβ Toxicity in Drosophila.Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.Metformin: are potential benefits on cancer risk extended to cancer survival?Metformin Impairs Spatial Memory and Visual Acuity in Old Male Mice.Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia.Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms.Effect of pioglitazone medication on the incidence of dementia.Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation.Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Metabolic control of the proteotoxic stress response: implications in diabetes mellitus and neurodegenerative disorders.Metformin as a Tool to Target Aging.Nutritional strategies to optimise cognitive function in the aging brain.Subchronic metformin pretreatment enhances novel object recognition memory task in forebrain ischemia: behavioural, molecular, and electrophysiological studies.
P2860
Q26741205-8108AB71-C58C-4E5F-986A-9ACF492651A9Q26777969-53A45373-3706-487F-AF5A-15C05B90BBCEQ26783344-DAC6E114-6C2D-4EF7-8522-B2711D1CF85EQ26825253-61641793-1C80-46E9-9B9A-5ABC1702DFDDQ27003253-86DA3560-D27C-4D4C-9789-EB93CBCD3CFCQ27022122-FD5AC4BA-D043-410F-8253-E7C52E54F639Q27301246-EA26EE78-D211-4EE1-BF2C-F63D357DA7B0Q28077202-09B95859-C77F-42E1-BE5F-0DC5F68CF29DQ28304338-DF3A8316-47DC-4A65-8015-C90BAA72BB6AQ28546258-BCC05CAB-0459-431B-B95F-BCB0035C9431Q29994589-39331E3F-EA5F-46A3-963D-D6573B92852FQ33780337-B4B72B11-36AF-475F-A3BD-A0F46BEA0190Q33799982-2CD23794-9D62-4AA0-A80C-320D1AFDA79EQ33800802-78AAFE3F-254E-4C28-9E5A-282B91373BE8Q34023537-B0F9B55A-5BE2-46A4-9824-E0336728416BQ34357962-314642DB-140A-4CE1-928D-E32402D0C76EQ34357977-CB9E5286-0EB7-4D45-84A2-D1C1DE542963Q34500113-9D39F927-3A34-4CD6-B663-B5867B7467F5Q35114494-03A5093F-DC7D-47A7-8A0C-B8F94DA7C9B6Q35691390-389CC2F6-5A2A-4682-9C46-0D6A87C1898DQ35733751-8DE67585-0614-40C9-8ACA-1CE02E5E8A08Q36771663-76CC5A86-2D6B-4DE1-A85E-A712E95CA71CQ36807576-68733095-A1E8-4A55-887E-A5E5BFC99630Q36860380-2964C6AF-0489-44E1-AECD-46323876D62AQ36881107-86A27860-2759-433A-8CFF-41725F51D9AFQ37262728-BF88ABCA-D3AA-4D6D-9F97-393D597204CCQ37364862-869E5044-4C2F-42F1-B591-A45E2791AD4CQ37404363-0AE99EFC-9374-49AD-AC35-24DF48837B18Q37619208-18EBDCFE-405A-4A72-9431-3C4BCA7B2517Q38234927-D57CB39B-F369-45CD-A257-985058123B9CQ38239648-79A13740-9C29-405F-9DB6-B920AF5B1ABEQ38253639-A922EEC0-9591-44AC-A08D-066E51475D46Q38414756-D78C142A-E0C2-42E1-806C-D6601529E091Q38416332-C06A4C95-D6EB-4950-9FD4-6B0B0E96D3ACQ38481462-BDE8E9F6-682A-45D9-9F40-7AFE3C65DFC0Q38673914-5D5CA2C5-01A5-4134-AC79-C49DF3908F74Q38862319-12F5F7FC-8EE2-4E9B-A4BB-AA53C0A26FC6Q38865781-1DA7EFF9-7572-4898-83CC-41B75DECC708Q38880656-CD0E806C-FEBA-4594-99DC-BD77DF723FBAQ39018499-C090602C-B616-4E91-983E-740EC6DD8ECD
P2860
Increased risk of cognitive impairment in patients with diabetes is associated with metformin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased risk of cognitive im ...... is associated with metformin.
@en
Increased risk of cognitive im ...... is associated with metformin.
@nl
type
label
Increased risk of cognitive im ...... is associated with metformin.
@en
Increased risk of cognitive im ...... is associated with metformin.
@nl
prefLabel
Increased risk of cognitive im ...... is associated with metformin.
@en
Increased risk of cognitive im ...... is associated with metformin.
@nl
P2093
P2860
P50
P356
P1433
P1476
Increased risk of cognitive im ...... is associated with metformin.
@en
P2093
AIBL Investigators
Alastair G Mander
Christopher Rowe
David A Watters
David Ames
Eileen M Moore
Karyn Boundy
Michael Woodward
Ross P Carne
P2860
P304
P356
10.2337/DC13-0229
P407
P50
P577
2013-09-05T00:00:00Z